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Racial Bias in Medical Treatment
Rene Bowser*
There is absolutely no doubt that Mr. North [a Black patient] is
treated differently than my White, middle-class patients are
treated... Every time I send him to a new consultant, I call
ahead with an introduction. I tell them how smart Mr. North is,
how compliant he is with every aspect of his treatment, and how
he knows so much about his medical condition and the
medications he takes. I hope that my introduction will enable
them to see my patient as I see him now, not as I saw him the
first time we met. He needs that chance in order to get the
medical care he requires and deserves.
-Neil S. Calman, M.D.1
I. Introduction
It may just be a coincidence. Open an issue of a recent medical
journal and one is likely to find a study showing that White patients
receive superior and more aggressive treatment than similarly
situated African-American patients. Open another issue, and one
is likely to find a study implying that African-American patients are
less likely to respond well to treatment, more likely to die from
expensive medical procedures, and more likely to possess more
virulent diseases and tumors. There is the clear inference that,
"these sorts of people don't do well."
Happenstance aside, it is likely that this latter category of race-
based research contributes to the medical treatment disparities that
we observe. Among the various fields that study human popula-
tions, only medicine and epidemiology stubbornly adhere to a
* Assistant Professor of Law, University of Illinois College of Law. This
paper was presented as part of the 2001 Mid-Atlantic People of Color Conference,
"Renaissance for a New Millennium: Identifying and Developing New Legal
Paradigms" held Feb. 1-3, 2001 at The Dickinson School of Law of The
Pennsylvania State University.
1. Neil S. Calman, Out of the Shadow: A White Inner-city Doctor Wrestles
With Racial Prejudice, 9 HEALTH AFFAIRS 170, 173 (2000).
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biological interpretation of race.2 Race is not a scientifically valid
concept and, therefore, the continuing use of race as a variable in
medical research reinforces pseudo-scientific understandings about
Black health.' These understandings, in turn, influence clinical
decision making.
Little has been written about racial bias in medical treatment.
Medicine is frequently idealized as a refuge from the pains of racial
politics that rend the fabric of American society. Explicit
discrimination against Blacks in all areas of medicine was the norm
until the passage of Title VI of the Civil Rights Act of 1964, and the
enactment of Medicare. Title VI forbade the distribution of federal
government funds to programs and institutions that discriminated
on the basis of race, creed, or national origin. 4 One year later,
President Lyndon B. Johnson signed the Medicare program into
law. Virtually every hospital in the country receives Medicare
funding. Thus, for the first time, African-Americans had a
legislative mandate that guaranteed the integration of most
hospitals and health care facilities.'
Despite the elimination of overt signs of racial discrimination,
African-Americans continue to experience poorer health outcomes
than any other racial or ethnic group in the United States.6 Some
observers insist that more money and more health insurance will
solve the problem of racial disparities in health, while others insist
that class and culture are the main issues, not race. These attempts
to define race-based health disparities in such neutral terms risk not
addressing the problem at all.'
2. Jay S. Kaufman & Richard S. Cooper, In Search of the Hypothesis: Racial
Differences and Disease, 110 PUB. HEALTH REP. 662, 663 (1995).
3. See Thomas A. LaVeist, Why We Should Continue to Study Race... But
Do a Better Job: An Essay on Race, Racism and Health, 6 ETHNICITY DISEASE 21,
21 (1996).
4. 42 U.S.C. § 2000d (1994) ("No person in the United States shall, on the
ground of race, color, or national origin, be excluded from participation in, be
denied the benefits of, or be subjected to discrimination under any program or
activity receiving Federal financial assistance.").
5. See, e.g., Sidney D. Watson, Reinvigorating Title VI: Defending Health
Care Discrimination-It Shouldn't Be So Easy, 58 FORDHAM L. REv. 939 (1990).
6. According to a University of Michigan study, the gap in death rates
between Blacks and Whites was as large five years ago as it was 50 years ago.
Although the overall death rates have declined for both Blacks and Whites, the
study finds, the racial gap is wider today than in 1950 for several leading causes of
death, including heart disease, cancer, diabetes, and cirrhosis of the liver. David
Williams, Race, Socioeconomic Status and Health: The Added Effects of Racism
and Discrimination, 896, ANNALS N.Y. ACAD. Sci. (Feb. 2000).
7. See W. Michael Byrd, Race, Biology, and Health Care: Reassessing A
Relationship, 1 J. HEALTH CARE FOR THE POOR AND UNDERSERVED 278, 279
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In this essay, I attempt to show that racial bias continues to
play an important role in medicine. The biomedical professions,
academic disciplines and medical practices reproduce and legiti-
mate biological and ideological mythologies about Black patients.
Clinical decisions regarding the diagnosis and prognosis of disease
among African-American patients are frequently influenced by
these meanings. The result in an institutionalized pattern or
practice of less treatment.
Given the contemporary African-American health crisis that
confronts the richest and most powerful nation in the world, one
which currently spends more of its resources on health care than
any other nation, an institutional analysis of the relationship
between race, health care and the medical and biological sciences is
needed.
II. The Problem
The most recent evidence shows that Black patients obtain less
aggressive treatment, experience lower rates of surgical treatment
and receive fewer referrals to specialists than their White peers.8
Compelling, and somewhat surprising, these latest studies join the
multitude of earlier ones that chronicle similar results.9
With major confounding variables like income, insurance
status and condition upon presentation increasingly controlled and
adjusted for, some investigators tend to invoke undocumented
patient preferences or an overuse of services by Whites as reasons
for the disparities. 1 Less circumspect researchers who do entertain
(1990).
8. While logic suggests that similar disparities may affect other cultural
and/or ethnic groups, this Article discusses the issue in terms of Black and White,
first, because the empirical studies have generally focused on Blacks and, second,
because other groups have had a different experience with medicine
9. A review prepared for the American Medical Association's Board of
Trustees restricted to the literature on treatment disparities appearing only in the
New England Journal of Medicine and the Journal of the American Medical
Association between 1984 and 1994 filled sixty-six pages. See H. Jack Geiger, Race
and Health Care-An American Dilemma, 336 NEw. ENG. J. MED. 816, 816 (1996).
This essay discusses the work published within the past few years. For a overview
of the earlier work, see Council on Ethical and Judicial Affairs, Black-White
Disparities in Health Care, 263 JAMA 2344 (1990); Mark B. Wenneker & Arnold
M. Epstein, Racial Inequalities in the Use of Procedures for Patients with Ischemic
Heart Disease in Massachusetts, 261 JAMA 253 (1989); Albert Oberman & Gary
Cutter, Issues in the Natural History and Treatment of Coronary Heart Disease in
Black Populations: Surgical Treatment, 108 AM. HEART J. 688 (1984); John Yergan
et al., Relationship Between Patient Race and the Intensity of Hospital Services, 25
MED. CARE 592 (1987).
10. 1 have discussed these explanations elsewhere and have concluded that the
20011
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the possibility of racial bias generally explain it as "unconscious
bias," without situating this term into the concrete context of
medical practice.
For the leading causes of death, Black patients receive inferior
care than similarly situated Whites. Heart disease is the leading
killer of Americans regardless of race." Yet, Black patients are
significantly less likely to undergo bypass surgery, coronary
angioplasty, or to receive cheap and effective treatments like
aspirin and beta blockers. 2
Similar disparities in medical treatment exist for cancer, the
second leading cause of death among African-Americans. 3 A
recent study shows that Black patients are less likely to receive
surgery for early stage lung cancer. 4 Moreover, a racial gap exists
in the administration of pain medication. For instance, one study
found that 65 percent of minority patients did not receive guideline-
recommended analgesic prescriptions compared with 50 percent of
non-Black patients." Furthermore, Black cancer patients
frequently receive less than optimal doses of radiation.
16
available evidence in support of these explanations is insufficient to exclude
institutional racism as the primary explanation for the observed racial differences.
Rene Bowser, Racial Bias in Medical Treatment (forthcoming 2001).
11. THE HENRY J. KAISER FAMILY FOUNDATION, KEY FACTS: RACE,
ETHNICITY & MEDICAL CARE, Figure 9 at p. 13. (October 1999).
12. See Marian E. Gornick et al., Effects of Race and Income on Mortality and
Use of Services Among Medicare Beneficiaries, 355 NEW. ENG. J. MED. 791 (1996);
Saith Raithore et al., Race, Sex, Poverty, and the Medical Treatment of Acute
Myocardial Infarction Among the Elderly, 102 CIRCULATION 642 (2000). The
researchers note that other studies have associated prompt administration of
antibiotics and collection of blood cultures with lower death rates. See also John
G. Canto et al., Relation of Race and Sex to the Use of Reperfusion Therapy in
Medicare Beneficiaries with Acute Myocardial Infarction, 342 NEW. ENG. J. MED.
1094 (2000) (finding that Blacks, regardless of sex, are significantly less likely to
receive reperfusion therapy after a heart attack).
13. HENRY J. KAISER FAMILY FOUNDATION, supra note 11.
14. Peter B. Bach et al., Racial Differences in the Treatment of Early-Stage
Lung Cancer, 341 NEW. ENG. J. MED. 1198 (1999). Non-small-cell cancer is
confined to the lung or regional lymph nodes without other metatastic spread.
There is agreement that the procedure of surgical resection saves lives in patients
with this condition. Bach et al. used Medicare hospitalization records to examine
the correlation between having a diagnosis of non-small-cell lung cancer (Stage I
or Stage II) and undergoing treatment by surgical resection. The authors
controlled for confounding effects such as income, availability of care and
coexisting illness.
15. Charles S. Cleeland et al., Pain and Treatment of Pain in Minority Patients
with Cancer, 127 ANNALS INTERN. MED. 813 (1997). The Cleeland study was
conducted at nine university cancer centers, seventeen community hospitals and
four centers that primarily test minority patients. Each institution is a member of a
consortium called the Eastern Cooperative Oncology Group. Id. at 813.
16. See MACK ROACH III, RACE AND THE CANCER RESEARCH LITERATURE:
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Stroke or cerebrovascular disease is the third leading cause of
death among African-Americans.17 Although Blacks have a higher
rate of death, White patients are four times more likely to receive
carotid endarterectomy, a preventive procedure that removes
plaque from the arteries that transport blood to and from the
brain."8
Finally, the fourth leading cause of death among African-
Americans is HIV/AIDS. 9 Whites suffering from this condition are
twice as likely to receive combination drug therapy, and 50 percent
more likely to receive preventive treatment for opportunistic
diseases such as pneumonia."
Additional evidence demonstrates that racial disparities cover
a host of diseases and exist across a spectrum of health care
settings. Moreover, these findings suggest that the legal and
organizational change from one system of health care, fee-for-
service, to another, managed care, has not eliminated practices and
patterns of behavior that have a negative impact on people of
color."
The disparities in medical treatment between Blacks and
Whites result in at least 60,000 excess deaths in the Black
population annually, according to one estimate.22 Besides causing
THE IMPACT ON HEALTH CARE DELIVERY AND POLICIES, UNIVERSITY OF
CALIFORNIA/HEALTH NET WELLNESS LECTURE SERIES 11, October 24, 1994 (copy
on file with the author).
17. HENRY J. KAISER FAMILY FOUNDATION, supra note 11.
18. See Elizabeth Mort et al., Physician Discretion and Racial Variation in the
Use of Surgical Procedures, 14 ARCH. INTERN. MED. 754, 766 (1994). Based on a
few studies involving a small number of Black patients, the conventional wisdom is
that Black patients have plaque deposits in the interior carotid arteries, whereas
White patients have such deposits in the exterior carotid arteries, which makes it
easier to surgically remove. See, e.g., Robert J. Wityk et al., Race and Sex
Differences in the Distribution of Cerebral Atherosclerosis, 27 STROKE 1974 (1996).
This taken-for-granted knowledge arguably channels physicians in the direction of
not providing the procedure for Black patients, even when it is clinically
appropriate. See Eugene Oddone et al., Race, Presenting Signs and Symptoms, Use
of Carotid Artery Imaging, and Appropriateness of Carotid Endarterectomy, 30
STROKE 1350 (1999) (finding that adjustment for appropriateness of carotid
endarterectomy reduces but does not eliminate the importance of race).
19. HENRY J. KAISER FAMILY FOUNDATION, supra note 11.
20. See, M.F. Shapiro et al., Variation in the Care of HIV-Infected Adults in the
United States: Results from the HIV Cost and Services Utilization Study, 281 JAMA
2305 (1999).
21. See David M. Carlisle et al., Racial and Ethnic Disparities in the Use of
Cardiovascular Procedures: Associations with Type of Health Insurance, 87 AM. J.
PUB. HEALTH 263, 266 (1997).
22. Charles DeShazer, M.D., Letter to the Editor, 342 NEw. ENG. J. MED. 518
(2000). DeShazer suggests that the magnitude of the problem is illustrated by
comparing this figure with the 58,000 deaths that occurred over a ten year period
2001]
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needless deaths and suffering, medical treatment disparities foster a
distrust of the health care system. As Vernellia R. Randall has
pointed out:
African-Americans receive health care treatment different from
the 'preferred' patient, the European American male...
Irrespective of race, each patient should be assured that the
physician will act in the patient's best interest... Under the
current situation, an African-American does not have those
assurances. Is there any wonder that African-Americans do not
trust the health care system?"
III. The Diagnosis-Medical Institutions Create a Self-
Perpetuating Mythology that Black Patients are Degenerate in
Relation to the White Norm
To understand the dynamics that contribute to racial bias in
medical treatment, this essay looks at clinical decision making from
an institutional perspective. The striking replication of racial
disparities across numerous medical diagnostic categories and in
nearly every type of health care setting strongly suggests that more
powerful forces are at work than the unconscious racism of some
White physicians.
An institutional analysis is helpful for two principle reasons.
First, it identifies and clarifies the symbiotic relationship between
actors who discriminate, on the one hand, and specific organiza-
tional practices, norms and processes that perpetuate discrim-
ination, on the other. Moreover, an institutional analysis addresses
the issue of effect and practice, rather than intent. Institutional
actors may harbor no racial prejudice but, nevertheless may help
perpetuate organizational patterns and processes that become self-
sustaining and discriminatory.24
Medical institutions, I suggest, carve up the world into
mutually exclusive domains of Black and White, each possessing
distinct meanings for physicians. These institutions express and
recreate generally negative understandings about Black patients.
Institutional bias in medicine is an unseen, self-sustaining force.
during the Vietnam War.
23. Vernellia R. Randall, Slavery, Segregation and Racism: Trusting the Health
Care System Ain't Always Easy! An African-American Perspective on Bioethics, 15
ST. Louis U. PUB. L. REV. 191, 215 (1996).
24. See Ian F. Haney Lopez, Institutional Racism: Judicial Conduct and a New
Theory of Racial Discrimination, 109 YALE L. J. 1717, 1761-1777 (2000).
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This essay turns to New Institutionalism to explain how these
institutions work.
New Institutionalism gives the term "institution" a distinct
technical meaning; it refers to self-perpetuating patterns and
practices made in reliance on taken-for-granted background
knowledge, rather than organizations.2  These patterns and
practices rely on and are antecedent to unspoken rules and
unexamined background knowledge-the "natural facts of life"
that any member of the organization knows.
Institutions in this technical sense are largely invisible and
typically rely on an analogy to nature so as not to be seen as a
contrived social arrangement formed to privilege one set of
competing interests over another.6 Moreover, institutionalized,
patterns and behaviors are reproduced because individuals can not
conceive of alternatives, or view alternatives as unrealistic.
Finally, institutions suffer from amnesia; the present is like no other
period and, therefore, present patterns and practices share no link
to the same activities performed in the past.2'
Not all institutions are racist. New Institutionalism defines
institutional racism as those self-perpetuating patterns and practices
made in reliance on taken-for-granted background knowledge
about race that serve to lower a particular racial group's status.
What, then, are the institutions in medicine that produce and
reinforce racial disparities in medical treatment? The first institu-
tion, I argue, is the practice of conducting comparative medical
studies of Blacks and Whites to understand the poorer health
outcomes of Blacks. I refer to this institution as racialized research.
A. Racialized Research Makes African-Americans Sick
Researchers conduct comparative medical and epidemiological
studies to explain observed differences in health outcomes between
Blacks and Whites. This work uses race as a variable to explain
differences in the incidence of disease among the "races", variations
25. See Ronald L. Jepperson, Institutions, Institutional Effects, and Institution-
alism, in THE NEW INSTITUTIONALISM IN ORGANIZATIONAL ANALYSIS 143 (Walter
W. Powell and Paul J. DiMaggio eds. 1991).
26. MARY DOUGLAS, How INSTITUTIONS THINK 45-50 (1986).
27. Paul J. DiMaggio & Walter W. Powell, Introduction to the New
Institutionalism in Organizational Analysis, in THE NEW INSTITUTIONALISM IN
ORGANIZATIONAL ANALYSIS 1, 14 (Paul J. DiMaggio and Walter W. Powell eds.
1991).
28. DOUGLAS, supra note 26, at 98-99.
29. See Haney Lopez, supra note 24, at 1809.
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in health outcomes, differences in survival rates from all types of
diseases, disparities in responses to treatments, and differences in
the etiology or pathways of disease.
Collectively, racialized research constructs Black patients as
degenerate in relation to the White norm. Blacks are viewed as
biologically different, and this work frequently infers that there
exists a genetic basis for disease in Blacks not found in Whites.
Based on these differences, racialized research reports that Blacks
respond more poorly to treatment, are more likely to die from
expensive invasive medical procedures, and possess more virulent
diseases and tumors.' Further, racialized research suggests that
Blacks are genetically disposed to a host of chronic diseases,
including hypertension, obesity, prostate cancer, low-birth weight
infants, left ventricular dysfunction, nicotine addiction, asthma, and
Alzheimer's disease.3
30. See, e.g., Charles R. Bridges et al., The Effect of Race on Coronary Bypass
Operative Mortality, 36 J. AM. COLL. CARDIOLOGY 1870, 1870 (2000) ("Black race
is an independent predictor of operative mortality after CABG except for high-
risk patients."); Richard J. Gray et al., Adverse 5-Year Outcome after Coronary
Artery Bypass Surgery in Blacks, 156 ARCH. INTERN. MED. 769, 771 (1996) ("Our
study shows a significantly higher mortality risk for Black patients after CAB
surgery."); Maria Mori Brooks et al., Predictors of Mortality and Mortality from
Cardiac Cause in the Bypass Angioplasty Revasculariztion Investigation (BARI)
Randomized Trial Registry, 101 CIRCULATION 2682, 2688 (2000) ("[B]lack race
remained a significant predictor of death after adjusting for internal artery use
during the [revascularization] procedure."); K. Rajender et al., Racial Differences
in Responses to Therapy with Interferon in Chronic Hepatitis C, 30 HEPATOLOGY
787, 791 (1999) ("Racial differences in response to therapies have been identified
in many diseases, including hypertension, diabetes, renal transplantation, and
depression." (citations omitted)); Respiratory Diseases Disproportionately Affec-
ting Minorities, 108 CHEST 1380, 1380 (1995) ("[S]everal studies comparing
minority with nonminority populations have noted differences in the incidence and
natural history of tuberculosis (TB), sarcoidosis, obstructive lung diseases, and
lung cancer."). The National Institutes of Health has concluded that Blacks have a
higher incidence of diabetes due to "unexplained genetic factors" and that excess
cancer rates in Blacks are due to "greater vulnerability to histologically aggressive
tumors (eg, of the uterus and bladder)." James B. Wyngaard, From the National
Institutes of Health, 261 JAMA 200 (1989).
31. See, e.g., Norman N. Kaplan, Ethnic Aspects of Hypertension, 344 LANCET
450 (1994); Anthony S. Robbins et al., Difference in Socioeconomic Status and
Survival Among White and Black Men with Prostate Cancer, 151 AM. J.
EPIDEMIOLOGY 409 (2000); Daniel L. Dries et al., Racial Differences in the
Outcome of Left Ventricular Dysfunction, 340 NEw ENG. J. MED. 606 (1999); John
C. Kleinman, Racial Differences in Low Birth Weight Infants, 317 NEw ENG. J.
MED. 749 (1987); M. Tang et al., Incidence of AD in African-Americans, Caribbean
Hispanics, and Caucasians in northern Manhattan, 56 NEUROLOGY 49 (2001);
Christine L. M. Joseph et al., Racial Differences in Physiologic Parameters Related
to Asthma Among Middle-Class Children, 117 CHEST 1336 (2000); Ralph S.
Carabello et al., Racial and Ethnic Differences in Serum Cotinine Levels of
Cigarette Smokers: Third National Health and Nutrition Examination Survey, 1988-
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Numerous papers published in the modern medical literature
also reference race as an independent risk factor related to survival
from prostate cancer, breast cancer, lung cancer, brain cancer,
colon cancer and esophageal cancer. 2 Moreover, Blacks are viewed
as having less favorable prognoses than White patients for other
medical conditions such as Hodgkin's disease.3
From a cultural perspective, Blacks are similarly viewed as
degenerate in relation to the White norm. Racialized research
suggests that Blacks are less likely to comply with medical
treatment, less likely to be knowledgeable about their disease, less
likely to view the disease as diminishing their quality of life, and
less likely to be involved in promoting their own health.'
Thus, as a general matter, racialized research collectively
fosters the background understanding that "these sorts of people
don't do well." Black difference and inferiority take on a rule-like
status and constitute the unquestioned background knowledge used
by researchers studying Black health. As I argue below, this
unconsidered background knowledge influences whether and how
physicians treat Black patients.
The current search for biological difference is undeniably
linked to the past. Historically, comparative medical studies were
intentionally undertaken to identify biological differences in Blacks
in order to stamp these individuals as inferior. The search for
difference was synonymous with the search for inferiority.
Medicine provided much of the theory and data that correlated
differences in skin color, hair texture, physical appearance, and
behavior between Blacks and Whites to confirm the superiority of
1991 280 JAMA 135 (1998).
32. See MACK ROACH III, RACE AND THE CANCER RESEARCH LITERATURE:
THE IMPACT ON HEALTH CARE DELIVERY AND POLICIES, UNIVERSITY OF
CALIFORNIAIHEALTH NET WELLNEss LECTURE SERIES, October 24, 1994 (copy on
file with the author). Dr. Roach summarizes and critiques numerous papers
published in the medical literature that imply that race is an independent risk
factor for cancer survival.
33. See Adel Zaki et al., Early and Late Survival in Hodgkin Disease Among
Whites and Blacks Living in the United States, 72 CANCER 602, 603 (1993).
34. See Dennis E. Daniels et al., Race: An Explanation of Patient Compliance
-Fact or Fiction, 86 J. NAT'L MED. ASS'N. 20 1994 (summarizing and refuting
studies showing that race is an independent predictor of adherence to a
hypertension reduction regime); M. A. Swanson et al., Noncompliance in Organ
Transplant Recipients, 11 PHARMACOTHERAPY 1735 (1991); M. Morgan, The
Significance of Ethnicity for Health Promotion: Patients' Use of Anti-hypertensive
Drugs in Inner London, 24 INT'LJ. EPIDEMIOLOGY (suppl. 1): S79-S84 (1995).
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Whites.35 Indeed, medicine played a crucial role in providing
"scientific" justifications for slavery and Jim Crow laws.'
While current methodologies are arguably more sophisticated,
the institution of searching for difference is the same. Fullilove puts
it this way:
All to often, when race is found to explain a significant portion
of the variation in some health outcome, little is done to explain
the meaning of the association. The result is that medical
researchers act as if there were inherent-if undefined-
differences between racial groups that, once signaled, require no
further explanation. In an odd way, there is little difference at
times between our modern science and the discredited practice
of using science and medicine to justify slavery in the
antebellum South: each assumes that racial differences are of
unquestioned importance.37
This is not to say that medical research is monolithic and that
current practices have gone unquestioned. Thoughtful researchers
have asked for a justification as to why "race" is so frequently used
as a key variable in medical and epidemiological research, when
only a small percentage of the variations between humans in total
genetic material can be attributed to differences in "race", and why
so many diseases are linked without proof to this small amount of
diversity.
Race is a social construct, not a scientific reality.38 Geneticists
have further shown that the differences between classically
described racial groups account for only 10 percent of genetic
variation (much of which is due to genes associated with skin
color).39 This figure is only slightly greater than the 6 percent
variation that exists between nations, such as the populations of
France and Spain, or between different tribes in Africa.'
35. See Patricia A King, Race, Justice, and Research, IN BEYOND CONSENT:
SEEKING JUSTICE IN RESEARCH 88, 92 (Jeffrey P. Kahn et al. eds. 1998).
36. See id.
37. Mindy Thompson Fullilove, Deconstructing Race in Medical Research, 148
ARCHIVES OF PEDIATRICS & ADOLESCENT MED. 1014, 1014-1015 (1994).
3& See generally, L. KAMIN ET AL., NOT IN OUR GENES: BIOLOGY, IDEOLOGY,
AND HUMAN NATURE (1984); Alan Almquist & John Cronin, Fact, Fancy and
Myth on Human Evolution, 29 CURRENT ANTHROPOLOGY 520 (1988).
39. Matstosi Nei & Arun K. Roychoudhury, 14 EVOLUTIONARY BIOLOGY 1,
11 (1982) ("[T]he proportion of genetic variation attributable to racial differences
is only about 9-11 percent"). Glass estimates that the number of gene differences
between, say, a West African and a native of Denmark may be very small and, on a
population basis, the "White race" differs from the "Black race" by no more than
six pairs of genes. B. GLASS, GENES AND THE MAN (1943).
40. See J. S. Jones, How Different are Human Races? 293 NATURE 188, 188-90
[Vol. 105:3
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Furthermore, greater genetic variation exists within the populations
categorized as Black and White than between these populations."
Consistent difference in one gene between populations is
extremely rare and accounts for only a tiny proportion of total
potential variation.42 The usually cited case, sickle cell anemia, is
the unusual case.43 Such a single gene abnormality can be handled
on its own merit without reference to dubious racial categories.
Genetic variation in a single gene, such as that for sickle cell anemia
in Blacks or Tay Sachs disease in Ashenazi Jews, does not imply
that populations that possess that gene will vary in important ways
for other health conditions.' Such a false analogy would suggest
that White Australians who possess a particular gene for skin
cancer are predisposed to other diseases.
The recent sequencing of the human genome provides
additional evidence that race has little biological meaning. As one
scientist has pointed out:
In view of the sad part that race and ethnicity still play in most
societies, concerns that genetic analyses of different human
populations could be abused are appropriate. Fortunately, from
the few studies of nuclear DNA sequences, it is clear that what
is called 'race', although culturally important, reflects just a few
continuous traits determined by a tiny fraction of our genes.
This tiny fraction gives no indication of variations at other parts
of our genome. Thus, from the perspective of nuclear genes, it
is often the case that two persons from the same part of the
world who look superficially alike are less related to each other
(1981).
41. Two persons of the same race could vary by thousands of genes. Lewontin
has estimated that diversity between individuals in a population accounts for 85
percent of species variation. Richard C. Lewontin, Apportionment of Human
Diversity, 6 EVOLUTIONARY BIOLOGY 381 (1972).
42. Monogenetic traits, such as sickle cell anemia and cystic fibrosis, where the
role of the environment is limited and there is no interaction with other genes,
make only a modest contribution to mortality in the United States. Monogenetic
traits, taken together, account for only about two percent of mortality. See Cooper
and Kaufman supra note 2, at 664.
43. The cell trait, although more common in Blacks, appears not to result from
race but from geographic origin. Sickle cell disease occurs in Whites both within
and outside the United States. The disease is most common in parts of the
world-equatorial Africa, the Mediterranean, and parts of Asia-where malaria
was common and is a protective adaptation to malaria. See, e.g., J. P. Ritchie & W.
S. Kerr, Sickle Cell Trait: Forgotten Cause of Hematuria in White Patients, 122 J.
UROLOGY 134 (1979); M. Caruso-Nicoletti et al., Growth and Development in
White Patients with Sickle Cell Diseases, 14 AM. PEDIATRIC HEMATOLOGY
ONCOLOGY 285 (1992).
44. Richard Cooper, A Note on the Biologic Concept of Race and Its
Application in Epidemiologic Research, 108 AM. HEART J. 715, 716-717 (1984).
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than they are to persons from other parts of the world who look
different.
45
Racialized research is also complicated by the problem of
perception. In nearly all racialized research published in the
United States, the comparison group has been the majority (White
population). Far from being a neutral category, this approach
consolidates Whites as the group with which all "others" should be
compared; it also disregards research that demonstrates the value of
studying variations in health among, say, African-Americans, as
opposed to always comparing them with White Americans.
The use of the white body as the point of comparison is neither
neutral nor objective. Whiteness is relational, and its use as a
scientific variable is inherently laden with meanings about differ-
ence, deviance and superiority. 6 Whiteness as a variable obscures
the heterogeneity among White populations and maintains White
race consciousness. It also allows researchers to ignore the social,
economic and political advantages of being White in the United
States, and the implications of such White privilege for health.
As Osbourne and Feit have put it: "The social consequences of
racial comparisons in medical publications may depend more on the
perceptions that adverse comparisons reinforce in society than on
the accuracy of the data, the intent of the authors, or the
correctness of their interpretations.41
After years of studying differences between Blacks and
Whites, there is little evidence that such research has paid positive
dividends to Blacks. As one prominent radiation and medical
oncologist has noted: "Thus far the designation of race as a major
health care variable has not resulted in the improvement of care for
anyone. Those who have benefited most from such practices have
been health care researchers.,
48
In the face of such criticism, there must be reasons why the
findings and conclusions of racialized research fill the pages of the
most prominent medical journals. The explanation is complex, but
at its simplest level, comparative research is self-sustaining because
the scientific truth obtained from prior research, that Blacks are
different, is accepted. The a priori sense of rightness of this
45. Svantee Paabo, The Human Genome and Our View of Ourselves, 291
SCIENCE 1219, 1219-1220 (2001).
46. See IAN F. HANEY LOPEZ, WHITE BY LAW (1996) (investigating and
illuminating centuries of legal interpretation of the term "white").
47. Newton G. Osborne and Marvin D. Feit, The Use of Race in Medical
Research, 267 JAMA 275, 278 (1992).
48. ROACH, supra note 32, at 12-13.
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background knowledge is unquestioned because it is founded on an
analogy to nature. In the minds of some, it seems "natural" that
people who have different genes for phenotypic traits like skin
color should also possess different genes for physiological function.
Thus, to understand the inferior health status of Blacks in this
country, researchers are institutionally channeled to look for the
genetic difference that causes a susceptibility to disease and a lower
survival rate once the disease has manifested itself. There are
differences among the races. But, institutional amnesia causes
them to ignore or forget the fact that, historically, racial
construction did not occur in a vacuum, but in the context of a
dominant ideology, perceived economic interests and psychological
necessity.
Racialized research is maintained and perpetuated because
many researchers can not imagine plausible alternative non-
biological explanations of the inferior health status of African
Americans. In the 19th century, progressive voices that argued that
the poor health status of Blacks was due to racism, rather than
innate racial differences, were silenced.4 9 Today, the institution of
racialized medical research continues this intellectual apartheid;
"White physicians who focus on racism as opposed to cultural
peculiarities or the genetic basis of disease are likely to be
considered both as not 'real scientists' and as dangerous."5 °
Starting with a belief in Black biological differences and some
statistical knowledge, a Black-White difference can almost always
be found.51  Research grants and evidence of "hard" clinical
research ability and productivity are vital in terms of prestige,
recognition and promotion.52 Racialized research is a major
industry, and showing difference enhances the researcher's status.3
49. Nancy Krieger, Shades of Difference: Theoretical Underpinnings of the
Medical Controversy on Black/White Differences in the United States, 1830-1870, 17
INT'L J. HEALTH SERV. 259, 272 (1987).
50. Waqar I. U. Ahmad, Making Black People Sick: "Race", Ideology and
Health Research, in "RACE" AND HEALTH IN CONTEMPORARY BRITIAN 26 (Waqar
I.U. Ahmad ed. 1993).
51. Kaufman & Cooper, supra note 2, at 665.
52. Ahmad, supra note 50, at 26.
53. Id. Ahmad observes that the literature is heavily skewed in this area,
reflecting the interests of researchers rather than the needs and priorities of
communities of color. Id. Such research, he notes, constructs Black health issues
based on a White agenda and "makes them sick." Id. See also, Paul Stubbs,
'Ethnically Sensitive' or 'Anti-Racist'? Models for Health Research and Service
Delivery, in "RACE" AND HEALTH IN CONTEMPORARY BRITAIN 34, 46 (Waqar
Ahmad ed. 1993). He suggests that research concerns tell us more about the
interests of the powerful than about Black people's and women's lives and health.
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As Kaufman and Cooper have pointed out: "Questionable
techniques may be retained if they provide what is believed to be
the 'right' answer, and in a society with deeply ingrained beliefs
about racial differences, a scientific confirmation of these
differences is the expected, and therefore the 'right', answer.
'
A
B. Bedside Bias and Racialized Research
Now the other half of the argument. This essay suggests that
physicians rely on the findings and conclusions of racialized
research in treating African-American patients. The result is a
pattern or practice of less treatment. I refer to this institution as
bedside bias.
In deciding whether or how to treat a Black patient, a
physician's decision is guided by the institutional understandings
about Black health. Clinical practice is increasingly evidence-
based. The "best evidence" is generally studies from the
biomedical literature that study treatment outcomes, survival rates,
prognoses and the like. The dubious findings and conclusions of
racialized research provide some of the "best evidence."
In a recent discussion on race and medicine, I asked a group of
about forty fourth-year medical students whether they would
recommend heart bypass surgery for a Black patient, given the fact
that the "best evidence" points to a substantially lower survival rate
for Blacks from this procedure. Although certainly not a scientific
survey, several students stated that they would use such evidence in
making a treatment decision based on a belief in the validity of the
survival data; others stated that because their education is heavily
evidence-based, they are expected to rely on such information.
Black students, however, stated that they would not rely on this
"best evidence" and, instead, would evaluate the patient on an
individualized basis.
Reliance on the taken-for-granted medical knowledge about
Black health also saves time and lowers transactions costs. Patient
race is one of the leadoff indicators in clinical rounds and medical
presentations.55 Physicians use race because they believe that it
Id.
54. Jay S. Kaufman et al., Socioeconomic Status and Health in Blacks and
Whites: The Problem of Residual Confounding and the Resiliency of Race, 8
EPIDEMIOLOGY 621, 627 (1997). This article provides the most comprehensive
methodological critique of comparative racial studies. The authors show that
variables such as income and education are often poorly specified and subject to
manipulation in order to achieve the desired result.
55. See Steven H. Caldell & Rebecca Poponoe, Perceptions and Misper-
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contains useful information, rather than being an unscientific,
socially constructed concept. In this regard, Steven Caldwell argues
that race "serves as little more than a 'jog' to the memory of busy
clinicians.56
White physicians spend less time with Black patients and
frequently, do not include Black patients in clinical decision
making. 7 By relying on taken-for-granted background information,
physicians may miss clinically relevant information, or assume the
presence or absence of genetic or cultural factors that, in fact, may
or may not be present. A physician might rule out autoimmune
hepatitis in a Black patient presenting with symptoms of fever,
malaise, weakness, nausea and abdominal distress because racial-
ized research indicates that this form of hepatitis is associated with
specific histocompatibility antigens, which are less prevalent in
Blacks. Instead, the patient may be diagnosed with another form of
hepatitis and given the incorrect treatment.
8
Of course, the cultural context of the physician/patient
relationship is another important consideration. 9 Patient race is
associated with physicians' assessment of patient intelligence,
feelings of affiliation toward the patient and beliefs about patients'
likelihood of substance abuse and non-compliance.' Moreover,
physician education contributes to the formation of medical
stereotypes. Group interaction and socialization into the medical
profession sustain and reinforce these views.61
ceptions of Skin Color, 122 ANN. INTERNAL MED. 614, 616 (1995).
56. Steven H. Caldell & Rebecca Poponoe, Perceptions and Misperceptions of
Skin Color, 122 ANN. INTERNAL MED. 614, 616 (1995).
57. See Lisa Cooper-Patrick et al., Race, Gender and Partnership in the Patient-
Physician Relationship, 282 JAMA 583 (1999).
58. See Calwell & Popenoe, supra note 55, at 614. See, also, Ritchie Witzig,
The Medicalization of Race: Scientific Legitimation of a Flawed Social Construct,
125 ANN. INTERNAL MED. 675, 677 (1996).
59. See, e.g., Jack A. Clark et al., Bringing Social Structure Back Into Clinical
Decision Making, 32 Soc. SCI. MED. 853, 853 (1991) (explaining that factors such
as race, age, gender, social class, characteristics of the physicians' professional
socialization and the organizational setting in which care is rendered determine the
shape and outcome of the clinical encounter).
60. See Michelle van Ryn & Jane Burke, The Effect of Patient Race and Socio-
economic Status on Physicians' Perceptions of Patients, 50 Soc. SCI. MED. 813
(2000).
61. In a May 2000 study, researchers at Duke University suggested that they
have found evidence that the attitudes that affect the behavior of doctors in
making treatment decisions based on race can be seen in the earliest stages of a
student's medical school experience. Racial and sexual biases surfaced when first
and second-year students were asked to assess the conditions of a Black woman
and a White man who they believed were real patients. In fact, the two were
actors using identical scripts describing symptoms of chest pain. See Saif S.
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The cultural context of the physician/patient encounter is
indirectly linked to the institution of racialized research. The use of
race as a scientific variable medicalizes difference; that is, it
legitimates and naturalizes racial categories. The reliance on
cultural stereotypes in the physician/patient encounter can be
reconceptualized as institutional racism because it treats race as an
unquestioned, natural part of the social order, and creates false and
unconsidered good/bad dichotomies that lower the health status of
Blacks.
Physicians, therefore, are not understood simply as unbiased
agents of science who display affective neutrality and objectivity
toward all patients. Indeed, assumptions about a disease can vary
based on the patient's "race., 62 As Harris argues, "[b]ackground
assumptions that shape how the body is formally or informally
categorized constitute its meaning for physicians."63
Many of these background assumptions are formed from
physician socialization and a reliance on the findings of racialized
research. The utility of a given procedure is often decided a priori,
without an individualized assessment of the patient's condition. It
is known that these sorts of people don't do very well. Writing
almost a century ago, W.E.B. Dubois made a similar observation:
"We must not forget that most Americans answer all queries
Rathore et al., The Effects of Patient Sex and Race on Medical Students' Ratings of
Quality of Life, 108 AM. J. MED. 561 (2000). With the information provided, the
medical students who had been taught the underlying physiologic relationship
between coronary artery disease and angina should have been able to diagnose a
condition of angina in both "patients." Instead, the White students, who made up
86 percent of the 164 participants in the study, were more likely to diagnosis
angina in the White "patient" than in the Black one (72 percent vs. 46 percent). In
contrast, the minority students made similar evaluations of the two patients. Id. at
563-64.
62. Leon Harris, Autonomy Under Duress, in AFRICAN-AMERICAN
PERSPECTIVES ON BIOMEDICAL ETHICS 145 (Harley Flack & Edmund D.
Pellegrino eds. 1992). Harris notes that the normative difference associated with
racial difference can potentially transform a physical ailment from a neutral object
for pure science or medicine to observe into an object containing a host of
meanings.
63. Id. at 145. More specifically, the traits associated with racial difference are
frequently endowed with an apparent reality and are used to construct disease
differently in Blacks than in Whites. Thus, a physical ailment is not simply an
object for pure medicine or science to observe, but an object embedded in a host
of perspectives that encode it with meaning. Id. at 144-145. As an example, the
social construction of syphilis in Black men shaped the infamous Tuskegee Syphilis
Study. Relying on unconsidered "scientific" knowledge, medicine constructed
syphilis in Black men to represent, among other things, Black promiscuity, the
different sexual nature of Blacks, and the assumption that Blacks would not seek
treatment for the disease. King, supra, note 35, at 96.
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regarding the Negro a priori, and that the least the human courtesy
can do is listen to the evidence. 64
III. The Remedies
The first step is to make medicine more inclusive. While
cultural sensitivity training has some value, deeply ingrained
attitudes and perceptions about race do not change quickly and
effortlessly. Medical schools must actively recruit non-majority
physicians to join the ranks of faculty. Members of these
communities are more likely to resist notions of Black inferiority,
reject biological and cultural stereotypes and to provide an
individualized assessment of a particular patient's complaints.65
Law also has a role to play in ending racial disparities in
medical treatment, namely. by enforcing civil rights legislation. In
1999, the United States Commission on Civil Rights criticized Title
VI enforcement efforts in the area of health care; the Commission's
report pointed out that the nondiscrimination provisions have not
been fully enforced and implemented by the Office of Civil Rights
(OCR), the branch of the Department of Health and Human
Services (HHS) charged with enforcement.'
64. W.E.B. Dubois, THE SOULS OF BLACK FOLK 75 (rev. ed. 1990).
65. An intensive effort by the Association of Medical Colleges helped to
produce a 36 percent increase in minority enrollment-to 12 percent-between
1990 and 1995. See David M. Carlisle et al., The Entry of Underrepresented
Minority Students into US Medical Schools: An Evaluation of Recent Trends, 88
AM. J. PUB. HEALTH 1314 (1998). But then the assault on affirmative action
began. First, California voters passed Proposition 209, an initiative flatly barring
so-called racial or ethnic preferences (even to pursue the goal of diversity) as a
factor in admission to the University of California system. In the Fifth Circuit, the
decision in Hopwood v. Texas, 78 F.3d 932 (5th Cir. 1996), cert. denied, 518 U.S.
1033 (1996), had the same effect for university admissions in Texas, Louisiana and
Mississippi. These attacks go much further than the landmark Bakke case, brought
by an unsuccessful applicant to the University of California, Davis, School of
Medicine, which stated that race could be a factor in admissions decisions.
Regents of Univ. of California v. Bakke, 438 U.S. 265 (1978) (Powell, J.). Justice
Powell argued "[the attainment of a diverse student body] clearly is a
constitutionally permissible goal for an institution of higher education." Id. at 311-
312.
Particularly disturbing is the fact that two-thirds of minority students
attending medical schools are enrolled in public institutions. Yet, nearly all of the
decline in minority student enrollment has occurred in public medical schools.
Public medical schools in California, Louisiana, Mississippi and Texas have been
disproportionately affected by this trend; collectively, medical schools in these
states accounted for 44 percent of the decrease in the enrollment of people of color
in 1996. See Carlise. If these trends continue, and there are strong reasons to
believe that they will, enrollment levels will likely return to the levels of the 1970s
or worse.
66. See U. S. COMM'N ON CIVIL RIGHTS. THE HEALTH CARE CHALLENGE:
2001]
DICKINSON LAW REVIEW
Obviously, OCR must take seriously its enforcement
obligations. One way to do this is to require each health care entity
that receives federal funds to collect and report data on racial
disparities in the use of services and the choices of diagnostic and
therapeutic alternatives. Existing "report cards" offer a system for
data collection; all that is needed is to stratify the reporting by race.
This proposal has the obvious advantage of withholding federal
funds from institutions that have statistically significant racial
disparities. Equally important, it would force institutions to think
about race and medical treatment.
As Sidney Watson has pointed out, "[i]t is only when providers
know that something is 'wrong' that they can be motivated to
change the status quo to do what is 'right'."67 An internal dialogue
on race might address these questions: Are Black and White
patients offered the same treatment options by physicians? Do
assumptions about survival affect physicians' recommendations for
certain procedures? Do physicians use racial stereotyping because
of time pressure? Are physicians' treatment decisions influenced
by racialized research that portrays Blacks as different and less
likely to respond well to certain treatments?
In the past, however, HHS has been hesitant to require
providers receiving federal funds to collect racial and ethnic data.
In one court challenge, HHS successfully argued that the collection
of statistical data on the ethnic distribution of health care services is
discretionary, not mandatory, under Title VI.6 HHS appears to be
reconsidering its position and has asked its Office of Minority
Health to study the issue.
IV. The Prognosis
The issue of minority health has occupied a high place on the
rhetorical agenda of recent presidential administrations. Lacking,
however, are both the needed financial resources and a commit-
ACKNOWLEDGING DISPARITY, CONFRONTING DISCRIMINATION, AND ENSURING
EQUALITY: A REPORT OF THE UNITES STATES COMMISSION ON CIVIL RIGHTS 6
(September 1999).
67. Sidney D. Watson, Health Care Divided: Race and Healing a Nation, 21 J.
LEGAL MED. 601, 607 (2001) (reviewing DAVID BARTON SMITH, HEALTH CARE
DIVIDED: RACE AND HEALING A NATION (1999)).
68. See Madison-Hughes v. Shalala, 80 F.3d 1121 (6th Cir. 1996) (challenging
HHS' failure to collect racial data concerning the delivery of health services that
would allow HHS to develop statistical data concerning minority access to
federally funded health care).
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ment to abandon some of the delusions about race that persist in
the politics of minority health improvement.
As an example, last year President Bill Clinton signed into law
the Minority Health and Health Disparities Research and
Education Act of 2000.69 The Act provides $150 million to establish
a center at the National Institutes of Health to study health
disparities among the nation's minority populations. ° The under-
lying goal is to eliminate racial disparities that result from the lack
of access to care, money and prevention. Significantly, however,
the Act does not mention racial bias in medical treatment as a
causative factor of these disparities.71
Racial disparities in medical treatment will continue so long as
we blind ourselves to the role of racial bias. Such bias leads to
needless suffering, countless excess deaths among the African-
American population, and perpetuates a legacy of distrust of the
health care system.
If change is to occur, civil rights organizations and community-
based health organizations must demand accountability from health
care providers, and push HHS to invigorate its Title VI enforce-
ment obligations. It is time to do away with incrementalism and
bandages. Indeed, eliminating racial discrimination in medical
treatment through invigorated Title VI enforcement must be
pursued with the same vigor that we have employed when working
towards eliminating barriers to other basic civil rights.
69. Minority Health and Health Disparities Research and Education Act of
2000, Pub. L. No. 106-525, 114 Stat. 2495 (2000).
70. Id. at sec. 101, § 485E(l), 114 Stat. 2495, 2501, sec. 201(b) 114 Stat. 2495,
2507.
71. Id. at sec. 2 (1) 114 Stat. 2495, 2496 ("Despite notable progress in the
overall health of the Nation, there are continuing disparities in the burden of
illness and death experienced by African Americans... compared to the United
States population as a whole."). The Act is part of a more ambitious effort to
eliminate racial disparities. In his radio address on February 21, 1998, President
Bill Clinton announced the goal of eliminating racial disparities in six areas by
2010: infant mortality, cancer screening and management, cardiovascular disease,
diabetes, HIV infection/AIDS and immunizations. This initiative is focused on
research to understand the reasons underlying racial/ethnic disparities, expanding
and improving programs to purchase or deliver health services, programs to reduce
poverty, programs to improve the safety and healthiness of children's environ-
ments, and expanded prevention efforts. See David Satcher, The Initiative to
Eliminate Racial and Ethnic Health Disparities is Moving Forward, 114 PUB.
HEALTH REP. 283 (1999).
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